Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary disease

BACKGROUND: Coadministration of mometasone furoate (MF) and formoterol fumarate (F) produces additive effects for improving symptoms and lung function and reduces exacerbations in patients with asthma and chronic obstructive pulmonary disease (COPD). The present study assessed the relative systemic...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Kosoglou, Teddy, Hubbell, James, Xuan, Fengjuan, Cutler, David L, Meehan, Alan G, Kantesaria, Bhavna, Wittmer, Bret A
Formato: Artigo
Idioma:Inglês
Publicado: Dove Medical Press 2013
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3595976/
https://ncbi.nlm.nih.gov/pubmed/23525511
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S36592
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares